Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Charcoal on Tiotropium Absorption
NCT03945344Phase 1Completed
- Sponsor
- Orion Corporation
- Start
- May 2019
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tiotropium in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Orion Corporation. Primary endpoint: Area Under Curve at 24 hours. Started May 2019; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03945344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03945344.